Elutia, Inc. (ELUT)
0.8198
-0.01
(-1.23%)
USD |
NASDAQ |
Sep 25, 16:00
0.81
-0.01
(-1.20%)
After-Hours: 19:59
Elutia Enterprise Value : 27.20M for Sept. 25, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 25, 2026 | 27.20M |
| September 24, 2026 | 27.66M |
| September 23, 2026 | 29.35M |
| September 22, 2026 | 26.78M |
| September 21, 2026 | 28.69M |
| September 18, 2026 | 28.54M |
| September 17, 2026 | 28.54M |
| September 16, 2026 | 26.77M |
| September 15, 2026 | 26.33M |
| September 14, 2026 | 25.66M |
| September 11, 2026 | 26.77M |
| September 10, 2026 | 26.34M |
| September 09, 2026 | 26.33M |
| September 08, 2026 | 27.66M |
| September 04, 2026 | 27.27M |
| September 03, 2026 | 28.10M |
| September 02, 2026 | 28.34M |
| September 01, 2026 | 29.03M |
| August 31, 2026 | 29.17M |
| August 28, 2026 | 29.87M |
| August 27, 2026 | 29.87M |
| August 26, 2026 | 35.19M |
| August 25, 2026 | 35.63M |
| August 24, 2026 | 33.19M |
| August 21, 2026 | 33.01M |
| Date | Value |
|---|---|
| August 20, 2026 | 30.84M |
| August 19, 2026 | 31.78M |
| August 18, 2026 | 31.20M |
| August 17, 2026 | 34.12M |
| August 14, 2026 | 32.57M |
| August 13, 2026 | 29.00M |
| August 12, 2026 | 27.12M |
| August 11, 2026 | 26.39M |
| August 10, 2026 | 26.95M |
| August 07, 2026 | 28.54M |
| August 06, 2026 | 29.91M |
| August 05, 2026 | 29.52M |
| August 04, 2026 | 29.52M |
| August 03, 2026 | 29.29M |
| July 31, 2026 | 28.84M |
| July 30, 2026 | 30.98M |
| July 29, 2026 | 29.87M |
| July 28, 2026 | 31.42M |
| July 27, 2026 | 33.43M |
| July 24, 2026 | 32.08M |
| July 23, 2026 | 32.20M |
| July 22, 2026 | 32.17M |
| July 21, 2026 | 32.97M |
| July 20, 2026 | 32.09M |
| July 17, 2026 | 32.97M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Agenus, Inc. | 628.60M |
| Amgen, Inc. | 267.45B |
| Anika Therapeutics, Inc. | 259.45M |
| BioCryst Pharmaceuticals, Inc. | 2.676B |
| Imunon, Inc. | 7.560M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -7.646M |
| Revenue (Quarterly) | 2.427M |
| Total Expenses (Quarterly) | 10.07M |
| EPS Diluted (Quarterly) | -0.1729 |
| Gross Profit Margin (Quarterly) | 59.62% |
| Profit Margin (Quarterly) | -315.0% |
| Earnings Yield | -82.42% |
| Normalized Earnings Yield | -79.23 |